Liansheng Wang

4.4k total citations
154 papers, 3.0k citations indexed

About

Liansheng Wang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Liansheng Wang has authored 154 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 48 papers in Cardiology and Cardiovascular Medicine and 35 papers in Surgery. Recurrent topics in Liansheng Wang's work include Cancer-related molecular mechanisms research (15 papers), Acute Myocardial Infarction Research (14 papers) and Cardiac Imaging and Diagnostics (13 papers). Liansheng Wang is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), Acute Myocardial Infarction Research (14 papers) and Cardiac Imaging and Diagnostics (13 papers). Liansheng Wang collaborates with scholars based in China, United States and Bangladesh. Liansheng Wang's co-authors include Changqian Wang, Shu Meng, Zhijian Yang, Zhouqing Huang, Ze‐Mu Wang, En‐Zhi Jia, Qiming Wang, Tiebing Zhu, Ting Chen and Yue Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Liansheng Wang

145 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liansheng Wang China 30 1.3k 641 528 478 346 154 3.0k
Lei Zhao China 27 1.1k 0.8× 520 0.8× 584 1.1× 374 0.8× 373 1.1× 103 2.9k
Xiao‐Ru Huang China 36 1.6k 1.2× 565 0.9× 332 0.6× 435 0.9× 762 2.2× 84 3.5k
Xufeng Tao China 29 1.3k 1.0× 346 0.5× 354 0.7× 342 0.7× 318 0.9× 66 2.7k
Leilei Ma China 30 1.2k 0.9× 378 0.6× 465 0.9× 272 0.6× 341 1.0× 90 2.7k
Heng Zhou China 30 1.8k 1.3× 623 1.0× 579 1.1× 192 0.4× 534 1.5× 72 3.1k
Chun Liang China 25 1.3k 1.0× 397 0.6× 465 0.9× 324 0.7× 363 1.0× 99 2.7k
Aijun Sun China 35 1.7k 1.3× 465 0.7× 1.1k 2.1× 791 1.7× 550 1.6× 130 3.8k
Zhijian Yang China 27 1.0k 0.8× 472 0.7× 453 0.9× 401 0.8× 157 0.5× 98 2.2k
Lu Gao China 30 1.4k 1.1× 712 1.1× 533 1.0× 238 0.5× 254 0.7× 143 2.8k
Anjana Munshi India 31 1.1k 0.8× 459 0.7× 377 0.7× 245 0.5× 205 0.6× 157 2.9k

Countries citing papers authored by Liansheng Wang

Since Specialization
Citations

This map shows the geographic impact of Liansheng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liansheng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liansheng Wang more than expected).

Fields of papers citing papers by Liansheng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liansheng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liansheng Wang. The network helps show where Liansheng Wang may publish in the future.

Co-authorship network of co-authors of Liansheng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Liansheng Wang. A scholar is included among the top collaborators of Liansheng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liansheng Wang. Liansheng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Lingling, Sibo Wang, Tongtong Yang, et al.. (2025). GPX3 Overexpression Ameliorates Cardiac Injury Post Myocardial Infarction Through Activating LSD1/Hif1α Axis. Journal of Cellular and Molecular Medicine. 29(3). e70398–e70398. 2 indexed citations
2.
Bao, Yi, Jiayi Chen, Jiayi Chen, et al.. (2025). Calbindin 2 as a Novel Biomarker and Therapeutic Target for Abdominal Aortic Aneurysm: Integrative Analysis of Human Proteomes and Genetics. Journal of the American Heart Association. 14(9). e039195–e039195.
3.
4.
Gu, Luo, Sibo Wang, Tongtong Yang, et al.. (2025). Targeting NLRC5 in cardiomyocytes protects postinfarction cardiac injury by enhancing autophagy flux through the CAVIN1/CAV1 axis. Communications Biology. 8(1). 292–292.
5.
Han, Xudong, Jiawen Chen, Tongtong Yang, et al.. (2024). Cellular nucleic acid binding protein facilitates cardiac repair after myocardial infarction by activating β-catenin signaling. Journal of Molecular and Cellular Cardiology. 189. 66–82. 5 indexed citations
6.
Bao, Yi, Luo Gu, Hao Wang, et al.. (2024). Autoimmune diseases and cardiovascular risk: Mendelian randomization analysis for the impact of 19 autoimmune diseases on 14 cardiovascular conditions. Journal of Translational Autoimmunity. 9. 100259–100259. 3 indexed citations
7.
Li, Bowen, Shule Xie, Jingjing Han, et al.. (2024). Neoadjuvant chemoimmunotherapy in resectable locally advanced oral squamous cell carcinoma: a single-center retrospective cohort study. International Journal of Surgery. 111(1). 781–790. 9 indexed citations
8.
Du, Chong, et al.. (2024). Identification of senescence related hub genes and potential therapeutic compounds for dilated cardiomyopathy via comprehensive transcriptome analysis. Computers in Biology and Medicine. 179. 108901–108901. 4 indexed citations
9.
Hu, Jintao, et al.. (2024). Predicting survival in patients with buccal cancer: A study based on SEER database and external validation in China. Cancer Medicine. 13(3). e6907–e6907. 1 indexed citations
10.
Chen, Jiawen, Tongtong Yang, Liuhua Zhou, et al.. (2023). SIRT3-dependent mitochondrial redox homeostasis mitigates CHK1 inhibition combined with gemcitabine treatment induced cardiotoxicity in hiPSC-CMs and mice. Archives of Toxicology. 97(12). 3209–3226. 2 indexed citations
11.
Zhou, Liuhua, Jiateng Sun, Tongtong Yang, et al.. (2023). Improved methodology for efficient establishment of the myocardial ischemia-reperfusion model in pigs through the median thoracic incision. Journal of Biomedical Research. 37(4). 302–302. 2 indexed citations
12.
Wang, Sibo, et al.. (2023). Association of glycation gap with all‐cause and cardiovascular mortality in US adults: A nationwide cohort study. Diabetes Obesity and Metabolism. 25(8). 2073–2083. 4 indexed citations
14.
Sun, Jiateng, Tongtong Yang, Jiawen Chen, et al.. (2022). CDK9 binds and activates SGK3 to promote cardiac repair after injury via the GSK-3β/β-catenin pathway. Frontiers in Cardiovascular Medicine. 9. 970745–970745. 6 indexed citations
15.
Wu, Yujie, Sibo Wang, & Liansheng Wang. (2022). SGLT2 Inhibitors: New Hope for the Treatment of Acute Myocardial Infarction?. American Journal of Cardiovascular Drugs. 22(6). 601–613. 7 indexed citations
16.
Xie, Zhiyong, Di Zhao, Bingrui Chen, et al.. (2017). Association between pet ownership and coronary artery disease in a Chinese population. Medicine. 96(13). e6466–e6466. 17 indexed citations
17.
Li, Q.S., et al.. (2016). Occurrence and pathogen composition of wheat crown rot in Hebei Province. 42(5). 154–157. 1 indexed citations
18.
Chen, Leilei, et al.. (2016). Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction. Cardiovascular Drugs and Therapy. 31(1). 9–18. 24 indexed citations
19.
Zhang, Dingguo, et al.. (2014). Rapid progression of nonculprit coronary lesions six weeks after successful primary PCI in culprit artery: a case report. Journal of Biomedical Research. 28(2). 146–146. 2 indexed citations
20.
Cheng, Zeneng, Yan Shu, Zhaoqian Liu, et al.. (2001). Role of cytochrome P450 in estradiol metabolism in vitro.. PubMed. 22(2). 148–54. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026